Wednesday, 23 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Policy / Regulatory
China Expands Medical Insurance Coverage to Include Assisted Reproductive Technology in 19 Regions
November 23, 2024
Company
BioAge Labs Taps Former GSK CEO Jean-Pierre Garnier as Chairman
November 23, 2024
Company
Policy / Regulatory
China’s NMPA Suspends Dr. Reddy’s Atomoxetine Imports Amid Quality Concerns
February 2, 2025
Company
Roche Diagnostics to Double Down on China with RMB 3 Billion Suzhou Plant Expansion
November 23, 2024
Company
Deals
WuXi Biologics to Acquire Full Control of Vaccine Contract Services Subsidiary for $108.5 Million
November 23, 2024
Company
Deals
Tiantan Biological to Acquire Wuhan Zhongyuan Ruide for $185 Million, Expanding Plasma Resources
November 23, 2024
Company
Junshi Biosciences Logs 17.37% Revenue Growth in 2024H1, Fueled by Loqtorzi Sales Surge
November 23, 2024
Company
MicroPort Medical Reports 17% Revenue Growth in 2024H1, Driven by Subsidiaries’ Performance
November 23, 2024
Company
Medical Device
Sino Medical Sciences Secures Hong Kong Approval for Coronary Balloon Dilation Catheter
October 13, 2024
1
2
…
23
24
25
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?